Literature DB >> 10026848

Functional involvement of CD44, a family of cell adhesion molecules, in immune responses, tumour progression and haematopoiesis.

U Günthert1, C Schwärzler, B Wittig, J Laman, P Ruiz, R Stauder, A Bloem, F Smadja-Joffe, M Zöller, A Rolink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10026848     DOI： 10.1007/978-1-4615-5357-1_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  8 in total

1.  CD44 participates in IP-10 induction in cells in which hepatitis C virus RNA is replicating, through an interaction with Toll-like receptor 2 and hyaluronan.

Authors:  Takayuki Abe; Takasuke Fukuhara; Xiauyu Wen; Akinori Ninomiya; Kohji Moriishi; Yoshihiko Maehara; Osamu Takeuchi; Taro Kawai; Shizuo Akira; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

2.  Short-term treatment with anti-CD44v7 antibody, but not CD44v4, restores the gut mucosa in established chronic dextran sulphate sodium (DSS)-induced colitis in mice.

Authors:  S Farkas; M Hornung; C Sattler; M Anthuber; U Gunthert; H Herfarth; H J Schlitt; E K Geissler; B M Wittig
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

3.  Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases.

Authors:  A Tzankov; A-C Pehrs; A Zimpfer; S Ascani; A Lugli; S Pileri; S Dirnhofer
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

Review 4.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

5.  The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells.

Authors:  Hirokatsu Osawa; Christian A Smith; Young Shin Ra; Paul Kongkham; James T Rutka
Journal:  Neuro Oncol       Date:  2008-12-16       Impact factor: 12.300

6.  Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance.

Authors:  M Athanassiou-Papaefthymiou; O Shkeir; D Kim; V Divi; M Matossian; J H Owen; M J Czerwinski; P Papagerakis; J McHugh; C R Bradford; T E Carey; G T Wolf; M E Prince; S Papagerakis
Journal:  Int J Immunopathol Pharmacol       Date:  2014 Jul-Sep       Impact factor: 3.219

7.  Alteration of the expression of CD44 [corrected] isoforms in oral epithelia and saliva from patients with oral lichen planus.

Authors:  Ponlatham Chaiyarit; Kobkan Thongprasom; Sajee Satayut; Kittipong Dhanuthai; Pornpan Piboonratanakit; Pensri Phothipakdee; Ajiravudh Subarnbhesaj; Supakit Limlertmongkol; Mantharop Chaimusig
Journal:  J Clin Immunol       Date:  2007-09-09       Impact factor: 8.317

8.  Ageing characteristics of bone indicated by transcriptomic and exosomal proteomic analysis of cortical bone cells.

Authors:  Chenyang Zhang; Shuyu Xu; Shufan Zhang; Mengmeng Liu; Haiming Du; Ruinan Sun; Bo Jing; Yao Sun
Journal:  J Orthop Surg Res       Date:  2019-05-10       Impact factor: 2.359
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.